4 research outputs found
Central Serous Chorioretinopathy in a 14-year-old atopic boy: a case report
Background: Corticosteroids are widely used in medicine. Few cases of central serous chorioretinopathy (CSC) have been reported following topical corticosteroid administration. We describe the first case of pediatric CSC related to topical corticosteroid administration. Case presentation: A 14-year-old boy presented with decreased vision, pigment epithelial detachments, and serous retinal detachments in the right eye after starting treatment for atopic dermatitis with Betamethasone Valerate 0.1% topical ointment. His condition resolved 2 weeks after discontinuing the steroid and administering Bromfenac 0.9 mg/ml eyedrops. Conclusions: Although the pathogenesis of CSC is poorly understood, ophthalmologists should be informed about the potential link between CSC and topical corticosteroid treatment, and they should be aware that CSC might, albeit infrequently, affect children
Macular Holes: Main Clinical Presentations, Diagnosis, and Therapies
Macular holes are a spectrum of retinal diseases that comprehends full-thickness macular holes (FTMHs), refractory/recurrent macular holes, lamellar macular holes (LMHs), myopic macular holes (MMHs), traumatic macular holes, and macular holes secondary to other retinal pathologies or injuries. There are various classifications of the subtypes of macular hole, and only in recent times researchers defined a common nomenclature, especially thanks to the evolution in retinal imaging, offered by new instruments like the swept-source OCT. The proposed therapies for macular holes are different and range from a "wait-and-see" approach to the vitrectomy, with different results in each subtype of macular hole. This narrative review has the purpose to investigate the available evidence in literature to give a summary of the knowledge about these retinal pathologies
Optic Nerve Sheath Diameter Ultrasound: Optic Nerve Growth Curve and its Application to Detect Intracranial Hypertension in Children
OCT Biomarkers in Neovascular Age-Related Macular Degeneration: A Narrative Review
Age-related macular degeneration (AMD) is the leading cause of legal blindness in elderly people. Neovascular AMD (nAMD) is
responsible for the majority of cases of severe visual loss in eyes with AMD. Optical coherence tomography (OCT) is the most
widely used technology for the diagnosis and follow-up of nAMD patients, which is widely used to study and guide the clinical
approach, as well as to predict and evaluate treatment response. &e aim of this review is to describe and analyze various structural
OCT-based biomarkers, which have practical value during both initial assessment and treatment follow-up of nAMD patients.
While central retinal thickness has been the most common and one of the first OCTidentified biomarkers, today, other qualitative
and quantitative biomarkers provide novel insight into disease activity and offer superior prognostic value and better guidance for
tailored therapeutic management. &e key importance of retinal fluid compartmentalization (intraretinal fluid, subretinal fluid,
and subretinal pigment epithelium (RPE) fluid) will be discussed firstly. In the second part, the structural alterations of different
retinal layers in various stages of the disease (photoreceptors layer integrity, hyperreflective dots, outer retinal tubulations,
subretinal hyperreflective material, and retinal pigment epithelial tears) will be analyzed in detail. &e last part of the review will
focus on how alterations of the vitreoretinal interface (vitreomacular adhesion and traction) and of the choroid (sub-RPE
hyperreflective columns, prechoroidal clefts, choroidal caverns, choroidal thickness and choroidal volume, and choroidal vascular
index) interact with nAMD progression. OCT technology is evolving very quickly, and new retinal biomarkers are continuously
described. &is up-to-date review article provides a comprehensive description on how structural OCT-based biomarkers provide
a valuable tool to monitor the progression of the disease and the treatment response in nAMD patients. &us, in this perspective,
clinicians will be able to allocate hospital resources in the best possible way and tailor treatment to the individual patient\u2019s needs